Farapulse Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 45

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $575M

Farapulse General Information

Description

Developer of catheter-based tools designed to treat atrial fibrillation. The company's products include offer over-the-wire, deflectable, linear, and circumferential lesion catheters that provide access to the outside of the heart and one lesion to isolate all the pulmonary veins, enabling physicians to make atrial fibrillation ablation safe, accessible, and less expensive for patients.

Contact Information

Website
www.farapulse.com
Formerly Known As
Iowa Approach, New IA
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3715 Haven Avenue
  • Suite 110
  • Menlo Park, CA 94025
  • United States
Primary Industry
Surgical Devices
Acquirer
Boston Scientific
Vertical(s)
Life Sciences
Corporate Office
  • 3715 Haven Avenue
  • Suite 110
  • Menlo Park, CA 94025
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Farapulse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 24-Jun-2021 $575M Completed Generating Revenue
8. Corporate 21-Sep-2020 Cancelled Generating Revenue
7. Later Stage VC (Series B) 17-Jan-2019 Completed Generating Revenue
6. Later Stage VC (Series A2) 10-Aug-2018 Completed Generating Revenue
5. Early Stage VC (Series A1) 01-Jun-2017 Completed Startup
4. Early Stage VC (Series A) 19-Feb-2016 Completed Startup
3. Early Stage VC 24-Nov-2014 Completed Startup
2. Grant 01-Jan-2013 $100K $15M Completed Startup
1. Seed Round 01-Jan-2012 $15M $15M Completed Startup
To view Farapulse’s complete valuation and funding history, request access »

Farapulse Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A2
Series A1 18,240,342 $0.001000 7% $0.28 $0.28 1x $0.28 5.15%
Series A 107,408,179 $0.001000 7% $0.23 $0.23 1x $0.23 30.31%
To view Farapulse’s complete cap table history, request access »

Farapulse Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of catheter-based tools designed to treat atrial fibrillation. The company's products include offer over-the-w
Surgical Devices
Menlo Park, CA
45 As of 2021

Epalinges, Switzerland
 

Burnaby, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Farapulse Competitors (3)

One of Farapulse’s 3 competitors is Argá Medtech, a Venture Capital-Backed company based in Epalinges, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Argá Medtech Venture Capital-Backed Epalinges, Switzerland
Kardium Venture Capital-Backed Burnaby, Canada
Acutus Medical Formerly VC-backed Carlsbad, CA
You’re viewing 3 of 3 competitors. Get the full list »

Farapulse Patents

  • 38

    Total Documents Applications and Grants

  • Total Patents Families

  • 28

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Farapulse Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230000548-A1 Focal ablation devices with foldable elements, and systems and methods thereof Pending 02-Jul-2021
US-11389234-B1 Systems, apparatuses, and methods for pre-ablation pulses in pulsed field ablation applications Active 11-Feb-2021
US-20220249157-A1 Systems, apparatuses, and methods for pre-ablation pulses in pulsed field ablation applications Active 11-Feb-2021
US-20230000547-A1 Systems, apparatuses, and methods for pre-ablation pulses in pulsed field ablation applications Pending 11-Feb-2021
US-20220071699-A1 Contoured electrodes for pulsed electric field ablation, and systems, devices, and methods thereof Pending 08-Sep-2020 A61B18/1492
To view Farapulse’s complete patent history, request access »

Farapulse Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Farapulse Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Deerfield Management Venture Capital Minority
Eight Roads Corporate Venture Capital Minority
F-Prime Capital Venture Capital Minority
Iowa Economic Development Authority Government
Plains Angels Angel Group Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Farapulse FAQs

  • When was Farapulse founded?

    Farapulse was founded in 2012.

  • Where is Farapulse headquartered?

    Farapulse is headquartered in Menlo Park, CA.

  • What is the size of Farapulse?

    Farapulse has 45 total employees.

  • What industry is Farapulse in?

    Farapulse’s primary industry is Surgical Devices.

  • Is Farapulse a private or public company?

    Farapulse is a Private company.

  • What is the current valuation of Farapulse?

    The current valuation of Farapulse is .

  • What is Farapulse’s current revenue?

    The current revenue for Farapulse is .

  • How much funding has Farapulse raised over time?

    Farapulse has raised $95.7M.

  • Who are Farapulse’s investors?

    Deerfield Management, Eight Roads, F-Prime Capital, Iowa Economic Development Authority, and Plains Angels are 5 of 7 investors who have invested in Farapulse.

  • Who are Farapulse’s competitors?

    Argá Medtech, Kardium, and Acutus Medical are competitors of Farapulse.

  • When was Farapulse acquired?

    Farapulse was acquired on 24-Jun-2021.

  • Who acquired Farapulse?

    Farapulse was acquired by Boston Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »